Try our Advanced Search for more refined results
Chiesi Farmaceutici SpA
-
Order | Filed: April 11, 2024 | Entered: April 11, 2024 Chiesi Farmaceutici S.p.A. et al v. Teva Pharmaceuticals Inc. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Order
STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf)
-
Utility | Filed: April 10, 2024 | Entered: April 10, 2024 Chiesi Farmaceutici S.p.A. et al v. Teva Pharmaceuticals Inc. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Case Assigned/Reassigned
Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)
-
Misc | Filed: April 08, 2024 | Entered: April 09, 2024 Chiesi Farmaceutici S.p.A. et al v. Teva Pharmaceuticals Inc. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Disclosure Statement - Rule 7.1
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Valline S.r.l. for Chiesi Farmaceutici S.p.A.; Corporate Parent Chiesi Farmaceutici S.p.A., Corporate Parent Amryt Pharmaceuticals Inc., Corporate Parent Amryt Pharma Holdings Limited, Corporate Parent Amryt Pharma Limited for Amryt Endo, Inc. filed by Amryt Endo, Inc., Chiesi Farmaceutici S.p.A. (apk)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login